Waystar Holding Corp. (WAY)

NASDAQ: WAY · Real-Time Price · USD
21.11
+0.17 (0.81%)
At close: Jul 31, 2026, 4:00 PM EDT
21.11
0.00 (-0.02%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Market Cap4.05B -34.8%
Revenue (ttm)1.21B +19.2%
Net Income134.79M +56.8%
EPS0.70 +45.5%
Shares Out 191.75M
PE Ratio29.98
Forward PE12.19
Dividendn/a
Ex-Dividend Daten/a
Volume3,860,861
Open21.85
Previous Close20.94
Day's Range21.08 - 22.33
52-Week Range17.26 - 41.47
Beta0.07
AnalystsStrong Buy
Price Target33.22 (+57.37%)
Earnings DateJul 29, 2026

About WAY

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.

Sector Healthcare
IPO Date Jun 7, 2024
Employees 1,700
Stock Exchange NASDAQ
Ticker Symbol WAY
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 24 analysts, the average rating for WAY stock is "Strong Buy." The 12-month stock price target is $33.22, which is an increase of 57.37% from the latest price.

Price Target
$33.22
(57.37% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Waystar price target raised to $39 from $36 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Waystar (WAY) to $39 from $36 and keeps a Buy rating on the shares.

2 days ago - TheFly

Waystar price target lowered to $32 from $34 at JPMorgan

JPMorgan lowered the firm’s price target on Waystar (WAY) to $32 from $34 and keeps an Overweight rating on the shares.

3 days ago - TheFly

Waystar price target lowered to $33 from $37 at UBS

UBS lowered the firm’s price target on Waystar (WAY) to $33 from $37 and keeps a Buy rating on the shares.

3 days ago - TheFly

Waystar price target lowered to $33 from $36 at Wells Fargo

Wells Fargo lowered the firm’s price target on Waystar (WAY) to $33 from $36 and keeps an Overweight rating on the shares. The firm says momentum increasingly centers on executing…

3 days ago - TheFly

Waystar names Alpana Wegner as CFO

Waystar (WAY) announced the appointment of Alpana Wegner as CFO, effective August 1. Wegner succeeds Steve Oreskovich, who has served as Waystar’s CFO for the past eight years and will…

4 days ago - TheFly

Waystar Holding Earnings Call Transcript: Q2 2026

Q2 2026 saw 18% revenue growth to $320M and a 43% adjusted EBITDA margin, driven by strong bookings, large client expansion, and robust demand for AI-powered solutions. Guidance for 2026 was raised, with continued investment in AI and automation, and a CFO transition announced.

4 days ago - Transcripts

Waystar Holding Earnings release: Q2 2026

Waystar Holding released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.

4 days ago - Filings

Waystar Holding Quarterly report: Q2 2026

Waystar Holding has published its Q2 2026 quarterly earnings report on July 29, 2026.

4 days ago - Filings

Waystar Holding Slides: Q2 2026

Waystar Holding has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.

4 days ago - Filings

Waystar reports Q2 adjusted EPS 43c, consensus 40c

Reports Q2 revenue $319.7M, consensus $316.17M. “Waystar (WAY) delivered another solid quarter, driven by healthy demand, disciplined execution, and growing provider adoption,” said Matt Hawkins, Chie...

4 days ago - TheFly

Waystar Announces Appointment of Alpana Wegner as Chief Financial Officer

Accomplished technology CFO to help advance Waystar's growth strategy and value creation LEHI, Utah and LOUISVILLE, Ky., July 29, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading heal...

4 days ago - PRNewsWire

Waystar Reports Second Quarter 2026 Results

Q2 revenue of $319.7M, up 18% YoY Q2 net income of $40.9M and non-GAAP net income of $83.3M Q2 net income margin of 13%; adjusted EBITDA margin of 43% Raising revenue and adjusted EBITDA guidance for ...

4 days ago - PRNewsWire

Waystar price target lowered to $28 from $30 at Citi

Citi analyst Daniel Grosslight lowered the firm’s price target on Waystar (WAY) to $28 from $30 and keeps a Buy rating on the shares. The firm adjusted ratings and targets…

10 days ago - TheFly

Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market

Report finds that clients using multiple Waystar capabilities achieve the strongest outcomes, highlighting the value of a single, connected platform LEHI, Utah and LOUISVILLE, Ky., July 21, 2026 /PRNe...

12 days ago - PRNewsWire

Kaskela Law LLC Announces Investigation of Waystar Holding Corp. (WAY) and Encourages Long-Term WAY Shareholders to Contact the Firm

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law is investigating Waystar Holding Corp. (Nasdaq: WAY) (“Waystar”) on behalf of the company's current shareholders. The investigation seeks to determine...

17 days ago - Business Wire

Waystar to Report Second Quarter 2026 Financial Results on July 29, 2026

LEHI, Utah and LOUISVILLE, Ky., July 15, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it will report financial results f...

18 days ago - PRNewsWire

Waystar initiated with an Overweight at KeyBanc

KeyBanc initiated coverage of Waystar (WAY) with an Overweight rating and $30 price target The firm sees a “large valuation disconnect” at current share levels given the company’s “high-margin growth…

4 weeks ago - TheFly

Waystar initiated with an Overweight at KeyBanc

KeyBanc initiated coverage of Waystar (WAY) with an Overweight rating and $30 price target

4 weeks ago - TheFly

Waystar to Host Investor Day at Waystar True North™ Conference on August 25, 2026

LEHI, Utah and LOUISVILLE, Ky., July 1, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it will host an Investor Day o...

4 weeks ago - PRNewsWire

Waystar price target lowered to $34 from $38 at JPMorgan

JPMorgan lowered the firm’s price target on Waystar (WAY) to $34 from $38 and keeps an Overweight rating on the shares. The firm adjusted targets in the health technology space…

5 weeks ago - TheFly

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., ...

7 weeks ago - PRNewsWire

Waystar Holding Transcript: 46th Annual William Blair Growth Stock Conference

AI-driven automation is reducing administrative costs and claim denials in healthcare, with rapid adoption leading to strong revenue and EBITDA growth. The platform's proprietary data and deep integration position it for continued expansion and innovation in a growing market.

2 months ago - Transcripts

Waystar Holding Slides: 46th Annual William Blair Growth Stock Conference

Waystar Holding has posted slides in relation to its latest quarterly earnings report, which was published on June 2, 2026.

2 months ago - Filings

Waystar Holding Transcript: AGM 2026

The meeting covered director elections, auditor ratification, and executive pay vote frequency, with all board recommendations approved by majority. Stockholders could participate virtually and submit questions after business concluded.

2 months ago - Transcripts

Waystar to Speak at William Blair Conference

LEHI, Utah and LOUISVILLE, Ky., May 20, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt H...

2 months ago - PRNewsWire